CRISPR gene editing: Can we make cancer cells easier to kill?

Researchers at the Gene Editing Institute have developed a CRISPR gene editing tool to disable genes causing resistance to standard care in cancer patients.

Lung cancer accounts for approximately one in five cancer deaths globally. The high death toll makes the development of new treatments and improvement of old ones a top priority. One of the challenges with traditional chemotherapy is that tumours can develop resistance to treatment. For several years, Eric B Kmiec, PhD, at the Gene Editing Institute of ChristianaCare, USA and […]

Read More… from CRISPR gene editing: Can we make cancer cells easier to kill?

Regulating RNA interference by modifying RNA backbone with amides

Professor Rozners and his team use nucleic acid chemistry to improve RNA-based technologies, modifying RNA backbone with amides

Professor Eriks Rozners and colleagues at Binghamton University in New York, USA, are using innovative nucleic acid chemistry to modify RNA-based technologies such as RNA interference (RNAi) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) to enhance their utility in molecular biology. These technologies suffer from off-target effects that limit their clinical utility. By replacing phosphates in the backbone with […]

Read More… from Regulating RNA interference by modifying RNA backbone with amides

Directed evolution of CRISPR-Cas9 to increase specificity

Directed evolution of CRISPR-Cas9 to increase specificity

Building upon previous CRISPR research and gene editing methods found in nature, Dr Lee and colleagues from ToolGen have developed a method of screening multiple Cas9 variants. Their method seeks to quickly and effectively screen many mutations of Cas9 to find one which possesses maximised on-target activity and minimised off-target activity. After successful development and implementation of the system, Sniper-Screen, […]

Read More… from Directed evolution of CRISPR-Cas9 to increase specificity